Mary Walsh
Articles
-
3 weeks ago |
healio.com | Erik Swain |Katie Kalvaitis |Mary Walsh
Tirzepatide improves outcomes in HFpEF, obesity regardless of kidney function• The clinical benefits of tirzepatide in patients with HFpEF and obesity were consistent regardless of kidney function. • The effect of tirzepatide on kidney function depends on how CKD is defined, researchers said.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →